Literature DB >> 12525277

Oral cancer treatment.

Terry A Day1, Betsy K Davis, M Boyd Gillespie, John K Joe, Megan Kibbey, Bonnie Martin-Harris, Brad Neville, Mary S Richardson, Steven Rosenzweig, Anand K Sharma, Michelle M Smith, Stacy Stewart, Robert K Stuart.   

Abstract

Oral cancer is the sixth most common cancer in the world, and it continues to represent a serious public health problem. Oral cancer is a preventable disease, related to behavioral and lifestyle factors, including tobacco and alcohol. Prevention and early detection of oral cancer remain the goals of national efforts to reduce the impact of this disease on the public. Surgical treatment is the mainstay of therapy for patients with oral cancer, particularly in advanced stages of cancer. External beam radiation therapy and brachytherapy have been used successfully as the primary modality for treating patients with early stage oral cancer, and they are the standard of care for use as adjuvant therapy in postoperative cases of patients with advanced stage oral cancer. There is an emerging trend for the use of chemotherapy in combination with radiation therapy and surgery for patients with advanced, recurrent, and metastatic head and neck cancer, although evidence is limited regarding survival benefit when used for treating patients with oral cavity carcinoma. Any report on the treatment of oral cancer is incomplete without consideration of functional and aesthetic outcomes, particularly addressing speech, swallowing, masticatory efficiency, and dental rehabilitation. Future generations will continue to fight these dreadful diseases until scientists and clinicians are provided the opportunities to expand efforts to prevent, detect (early), and eradicate oral and other head and neck cancers.

Entities:  

Mesh:

Year:  2003        PMID: 12525277     DOI: 10.1007/s11864-003-0029-4

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  109 in total

1.  Prognostic indicators of occult metastases in oral cancer.

Authors:  Mario Russolo; Vittorio Giacomarra; Ledia Papanikolla; Giancarlo Tirelli
Journal:  Laryngoscope       Date:  2002-07       Impact factor: 3.325

Review 2.  Squamous cell carcinoma of the oropharynx and oral cavity: how imaging makes a difference.

Authors:  S K Mukherji; J Castelijns; M Castillo
Journal:  Semin Ultrasound CT MR       Date:  1998-12       Impact factor: 1.875

3.  Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group.

Authors:  J J Sciubba
Journal:  J Am Dent Assoc       Date:  1999-10       Impact factor: 3.634

Review 4.  Loss of heterozygosity: a potential tool in management of oral premalignant lesions?

Authors:  L Zhang; M P Rosin
Journal:  J Oral Pathol Med       Date:  2001-10       Impact factor: 4.253

5.  Concomitant chemotherapy and split-course radiation for cure and preservation of speech and swallowing in head and neck cancer.

Authors:  S M Hirsch; D D Caldarelli; J C Hutchinson; L D Holinger; A K Murthy; J L Showell; S G Taylor
Journal:  Laryngoscope       Date:  1991-06       Impact factor: 3.325

6.  Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment.

Authors:  M Partridge; S R Li; S Pateromichelakis; R Francis; E Phillips; X H Huang; F Tesfa-Selase; J D Langdon
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

7.  The incidence of p53 mutations increases with progression of head and neck cancer.

Authors:  J O Boyle; J Hakim; W Koch; P van der Riet; R H Hruban; R A Roa; R Correo; Y J Eby; J M Ruppert; D Sidransky
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

8.  Carcinoma of the lip and selected sites of head and neck skin. A clinical study of 896 patients.

Authors:  Z Petrovich; R G Parker; G Luxton; H Kuisk; J Jepson
Journal:  Radiother Oncol       Date:  1987-01       Impact factor: 6.280

9.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.

Authors:  D M Brizel; M E Albers; S R Fisher; R L Scher; W J Richtsmeier; V Hars; S L George; A T Huang; L R Prosnitz
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

10.  Speech and swallow function after tonsil/base of tongue resection with primary closure.

Authors:  J A Logemann; B R Pauloski; A W Rademaker; F M McConnel; M A Heiser; S Cardinale; D Shedd; D Stein; Q Beery; J Johnson
Journal:  J Speech Hear Res       Date:  1993-10
View more
  29 in total

1.  Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma.

Authors:  Daniel J Rohrbach; Nestor Rigual; Hassan Arshad; Erin C Tracy; Michelle T Cooper; Gal Shafirstein; Gregory Wilding; Mihai Merzianu; Heinz Baumann; Barbara W Henderson; Ulas Sunar
Journal:  J Biomed Opt       Date:  2016-01       Impact factor: 3.170

Review 2.  Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.

Authors:  Thomas H Beckham; Saeed Elojeimy; Joseph C Cheng; Lorianne S Turner; Stanley R Hoffman; James S Norris; Xiang Liu
Journal:  Expert Opin Ther Targets       Date:  2010-05       Impact factor: 6.902

Review 3.  The pivotal role of pathology in the management of lung cancer.

Authors:  Morgan R Davidson; Adi F Gazdar; Belinda E Clarke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

4.  Identification and evaluation of novel drug combinations of Aurora kinase inhibitor CCT137690 for enhanced efficacy in oral cancer cells.

Authors:  Muhammad Furqan; Zille Huma; Zainab Ashfaq; Apsra Nasir; Rahim Ullah; Aishah Bilal; Maheen Iqbal; Muhammad Hashaam Khalid; Irshad Hussain; Amir Faisal
Journal:  Cell Cycle       Date:  2019-07-26       Impact factor: 4.534

5.  The "Comprehensive ICF Core Set for Head and Neck Cancer": a Delphi consensus survey among German speaking speech and language therapists.

Authors:  Matthias Engelbarts; Vanessa Schuster; Ulrich Kisser; Carla Sabariego; Marita Stier-Jarmer; Michaela Coenen; Benjamin Philipp Ernst; Sebastian Strieth; Ulrich Harréus; Sven Becker
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-24       Impact factor: 2.503

6.  Stigma and related influencing factors in postoperative oral cancer patients in China: a cross-sectional study.

Authors:  Chuxia Tan; Chenxi Zhong; Ranran Mei; Ronghong Yang; Dangdang Wang; Xianjiao Deng; Shihao Chen; Man Ye
Journal:  Support Care Cancer       Date:  2022-03-19       Impact factor: 3.603

7.  Antiproliferative effect of Tualang honey on oral squamous cell carcinoma and osteosarcoma cell lines.

Authors:  Abdulmlik A Ghashm; Nor H Othman; Mohammed N Khattak; Noorliza M Ismail; Rajan Saini
Journal:  BMC Complement Altern Med       Date:  2010-09-14       Impact factor: 3.659

8.  Rehabilitation of dysphagia following head and neck cancer.

Authors:  Barbara R Pauloski
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-11       Impact factor: 1.784

9.  Effects of a concurrent chemoradiotherapy with S-1 for locally advanced oral cancer.

Authors:  Satoshi Hino; Hiroyuki Hamakawa; Youji Miyamoto; Kazuo Ryoke; Jyouji Sekine; Akira Sasaki; Tetsuya Yamamoto
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

10.  Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.

Authors:  Nestor Rigual; Gal Shafirstein; Michele T Cooper; Heinz Baumann; David A Bellnier; Ulas Sunar; Erin C Tracy; Daniel J Rohrbach; Gregory Wilding; Wei Tan; Maureen Sullivan; Mihai Merzianu; Barbara W Henderson
Journal:  Clin Cancer Res       Date:  2013-10-02       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.